Vascular Dementia Market Size, Share, Trends, Growth, Leading Companies, Emerging Drugs, and Epidemiology Forecast

March 10 14:16 2021
Delveinsight Business Research LLP

DelveInsight’s “Vascular Dementia Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Vascular Dementia, historical and forecasted epidemiology as well as the Vascular Dementia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

According to the Alzheimer’s Association, Vascular dementia is a decline in thinking skills caused by conditions that block or reduce blood flow to various regions of the brain, depriving them of oxygen and nutrients. Inadequate blood flow can damage and eventually kill cells anywhere in the body, but the brain is especially vulnerable.

The diagnosis of Vascular dementia is difficult due to the number and types of lesions and their locations in the brain. Consensus and accurate diagnosis of clinically suspected VaD rely on wide-ranging clinical, neuropsychological, and neuroimaging measures. The diagnosis of dementia or mild cognitive impairment is confirmed by neurocognitive testing.

Get FREE sample copy at: 
https://www.delveinsight.com/sample-request/vascular-dementia-market

The Vascular Dementia market report also covers emerging drugs, current treatment practices, Vascular Dementia market share of the individual therapies, current and forecasted Vascular Dementia Market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Vascular Dementia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market. 

Vascular Dementia Market

Vascular Dementia Market Key Facts

  • According to a study titled “Vascular dementia: diagnosis, treatment and medical management”, (2019), in the UK, an estimated 954,000 people have dementia, 162,197 have vascular dementia (VaD). Some 95,410 have mixed dementia, which is a mixture of vascular dementia and Alzheimer’s disease.

  • According to a study by Podcasy J. L. et al, (2016), males are at greater risk of developing vascular dementia.

Key Benefits of Vascular Dementia Market Report

  • Vascular Dementia market report provides an in-depth analysis of Vascular Dementia Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major markets i.e. EU5 (Germany, Italy, Spain, France, and the UK), Japan, and the United States.

  • The Vascular Dementia market report will help in developing business strategies by understanding the Vascular Dementia Market trends & developments, key players, and future market competition that will shape and drive the Vascular Dementia market in the upcoming years.

  • The Vascular Dementia market report covers Vascular Dementia’s current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Vascular Dementia market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

Vascular Dementia Market

The Vascular Dementia market size is expected to increase during the forecast period owing to the expected launch of therapies, increase in government initiatives, extensive research and development activities of pharmaceutical companies.

The Vascular Dementia market outlook section of the report helps to build a detailed comprehension of the historic, current and forecasted Vascular Dementia market trends by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Vascular Dementia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

Vascular Dementia Epidemiology

The Vascular Dementia epidemiology section covers insights about the historical and current Vascular Dementia patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Vascular Dementia Drugs Uptake and Key Market Players

The Vascular Dementia Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Vascular Dementia market or expected to get launched in the market during the study period. The analysis covers Vascular Dementia market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Vascular Dementia Companies:
Otsuka and Lundbeck
Eisai
And others.

Vascular Dementia therapies covered in the report include Brexpiprazole, E2027, and many others.

Table of Content

1. Key Insights

2. Executive Summary 

3. Vascular Dementia Competitive Intelligence Analysis

4. Vascular Dementia Market Overview at a Glance

5. Vascular Dementia Disease Background and Overview

6. Vascular Dementia Patient Journey

7. Vascular Dementia Epidemiology and Patient Population

8. Vascular Dementia Treatment Algorithm, Current Treatment, and Medical Practices

9. Vascular Dementia Unmet Needs

10. Key Endpoints of Vascular Dementia Treatment

11. Vascular Dementia Marketed Products

12. Vascular Dementia Emerging Therapies

13. Vascular Dementia Seven Major Market Analysis

14. Attribute Analysis

15. Vascular Dementia Market Outlook (7 major markets)

16. Vascular Dementia Access and Reimbursement Overview

17. KOL Views on the Vascular Dementia Market.

18. Vascular Dementia Market Drivers

19. Vascular Dementia Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Related Reports
Vascular Dementia Pipeline Insights
Vascular Dementia Pipeline Insight, 2020 report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the Vascular Dementia market.

Latest Reports by Delveinsight – 
Hemophagocytic Lymphohistiocytosis Market Forecast
DelveInsight’ s “Hemophagocytic Lymphohistiocytosis Market Insights, Epidemiology, and Market Forecast 2030” report provides a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology and the Hemophagocytic Lymphohistiocytosis market size, share, trends, and forecast for the seven major markets (i.e. the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd. 2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

  Categories: